Chris Meyer Email

VP Clinical Operations . Inhibikase Therapeutics

ATLANTA, GA

Location

Current Roles

Employees:
8
Revenue:
$804k
About
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Inhibikase Therapeutics Address
3350 Riverwood Parkway
ATLANTA, GA
Inhibikase Therapeutics Email

Past Companies

Inhibikase Therapeutics, Inc.Vice President of Clinical Operations
Axial Therapeutics, Inc.Vice President Operations
Axial Biotherapeutics, Inc.Senior Director Program Management

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.